ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
0,00%
Dow Jones
41 433,48
-1,14%
DAX
22 328,77
-1,23%
Brent Oil
69,465
-0,36%
Bitcoin
81 642,65
-1,46%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Jazz Pharmaceuticals PLC (JAZZ) Cours

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC (JAZZ)

NASDAQ
136,86
-0,59
(-0,43%)
Fermé 12 Mars 9:00PM
Retardé de 15 minutes
137,50
0,64
(0,47%)
Après les heures de négociation: 11:35PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
137,50
Prix Achat
130,00
Prix Vente
145,00
Volume échangé
910 374
134,6175 Fourchette du Jour 138,59
99,06 Plage de 52 semaines 148,0568
Cap du marché
8,351B
Clôture Veille
137,45
Ouverture
137,06
Dernière Transaction
1
@
135.17
Dernière heure de transaction
Volume financier
US$ 124 478 651
VWAP
136,7335
Volume moyen (3 m)
760 813
Actions en circulation
60 732 479
Rendement du Dividende
-
Ratio Cours sur Bénéfices
14,84
Bénéfice par action (BPA)
9,22
Chiffre d'affairess
4,07B
Bénéfice net
560,12M

À propos de Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of met... Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.jazzpharma.com
Siège social
Dublin, Irl
Fondé
-
Jazz Pharmaceuticals PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker JAZZ. Le dernier cours de clôture d'Jazz Pharmaceuticals était de US$137,45. Au cours de la dernière année, les actions de Jazz Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 99,06 à US$ 148,0568.

Jazz Pharmaceuticals compte actuellement 60 732 479 actions en circulation. La capitalisation boursière d'Jazz Pharmaceuticals est de US$8,35 milliard. Jazz Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 14.84.

Flux d'options Jazz Pharmaceuticals (JAZZ)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

26k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

JAZZ Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
il y a 8 heures
JAZZ (-0,43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
il y a 8 heures
JAZZ (-0,43%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
10 Mars 2025
JAZZ (-0,43%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
10 Mars 2025
JAZZ (-0,43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 Mars 2025
JAZZ (-0,43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 Mars 2025
JAZZ (-0,43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 Mars 2025
JAZZ (-0,43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 Mars 2025
JAZZ (-0,43%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 Mars 2025
JAZZ (-0,43%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 Mars 2025
JAZZ (-0,43%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.93-1.38420712903139.43142.93135.361137757138.29363998CS
414.2611.5709185329123.24148.0568123.011125737138.43506654CS
1213.7111.0752080136123.79148.0568118.72760813130.85781747CS
2630.5128.5166838022106.99148.0568104.42679939123.42966892CS
5220.4917.5113238185117.01148.056899.06700639116.7996869CS
156-18.07-11.6153500032155.57169.9899.06604884130.71313988CS
26027.3524.829777576110.1518986.88628754135.43760877CS

JAZZ - Frequently Asked Questions (FAQ)

What is the current Jazz Pharmaceuticals share price?
The current share price of Jazz Pharmaceuticals is US$ 137,50
How many Jazz Pharmaceuticals shares are in issue?
Jazz Pharmaceuticals has 60 732 479 shares in issue
What is the market cap of Jazz Pharmaceuticals?
The market capitalisation of Jazz Pharmaceuticals is USD 8,35B
What is the 1 year trading range for Jazz Pharmaceuticals share price?
Jazz Pharmaceuticals has traded in the range of US$ 99,06 to US$ 148,0568 during the past year
What is the PE ratio of Jazz Pharmaceuticals?
The price to earnings ratio of Jazz Pharmaceuticals is 14,84
What is the cash to sales ratio of Jazz Pharmaceuticals?
The cash to sales ratio of Jazz Pharmaceuticals is 2,04
What is the reporting currency for Jazz Pharmaceuticals?
Jazz Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Jazz Pharmaceuticals?
The latest annual turnover of Jazz Pharmaceuticals is USD 4,07B
What is the latest annual profit for Jazz Pharmaceuticals?
The latest annual profit of Jazz Pharmaceuticals is USD 560,12M
What is the registered address of Jazz Pharmaceuticals?
The registered address for Jazz Pharmaceuticals is 15TH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, D04 E5W7
What is the Jazz Pharmaceuticals website address?
The website address for Jazz Pharmaceuticals is www.jazzpharma.com
Which industry sector does Jazz Pharmaceuticals operate in?
Jazz Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAYRaytech Holding Ltd
US$ 1,69
(94,25%)
104,03M
TSVT2seventy bio Inc
US$ 4,945
(76,61%)
31,49M
HSAIHesai Group
US$ 24,10
(50,53%)
26,82M
SPHLSpringview Holdings Ltd
US$ 6,00
(47,06%)
1,63M
SYRSSyros Pharmaceuticals Inc
US$ 0,1334
(45,63%)
695,66M
WCTWellchange Holdings Company Limited
US$ 0,68417
(-72,74%)
37,72M
ARVNArvinas Inc
US$ 8,29
(-52,79%)
19,03M
LZMHLZ Technology Holdings Ltd
US$ 8,011
(-48,84%)
685,95k
HTCOHigh Trend International Group
US$ 1,41
(-33,80%)
188,46k
SPGCSacks Parente Golf Inc
US$ 0,1061
(-33,73%)
36,38M
SYRSSyros Pharmaceuticals Inc
US$ 0,1334
(45,63%)
695,66M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0402
(20,00%)
411,84M
NVDANVIDIA Corporation
US$ 108,76
(1,66%)
354,43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,93
(7,45%)
304,67M
CUTRCutera Inc
US$ 0,1079
(-16,03%)
218,46M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces